Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoto Tamura

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Rheumatology International|May 9, 2022
Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritisKeisuke Ono, Mitsumasa Kishimoto, Gautam A Deshpande, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 15, 2026
Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel VasculitisTsuyoshi Shirai, Tsuneyasu Yoshida, Eri Sugano, et al.
Annals of the Rheumatic Diseases|April 17, 2012
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target moleculesRyoko Sakai, Michi Tanaka, Toshihiro Nanki, et al.
Modern Rheumatology|May 26, 2023
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI)Kenta Misaki, Naoto Tamura, Takanori Azuma, et al.
RMD Open|July 10, 2026
Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populationsAya Kawasaki, Ikue Ito-Naito, Mina Sato, et al.
The Journal of Rheumatology|February 17, 2019
Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the WorldMitsumasa Kishimoto, Kazuki Yoshida, Naomi Ichikawa, et al.
Modern Rheumatology|February 19, 2026
Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicenter cohort study (J-CANVAS)Motoki Takeuchi, Yoshiyuki Abe, Ayako Makiyama, et al.
Modern Rheumatology|February 8, 2022
Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren's syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren's Syndrome Endocrinopathy) and ROSE II trialsHiroto Tsuboi, Hirofumi Toko, Fumika Honda, et al.
Lupus|May 6, 2026
Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritisYoshiyuki Abe, Ayako Makiyama, Kentaro Minowa, et al.
Modern Rheumatology|November 10, 2017
Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC)Kenji Oku, Tatsuya Atsumi, Yuji Akiyama, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Rheumatology International|May 9, 2022
Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritisKeisuke Ono, Mitsumasa Kishimoto, Gautam A Deshpande, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 15, 2026
Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel VasculitisTsuyoshi Shirai, Tsuneyasu Yoshida, Eri Sugano, et al.
Annals of the Rheumatic Diseases|April 17, 2012
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target moleculesRyoko Sakai, Michi Tanaka, Toshihiro Nanki, et al.
Modern Rheumatology|May 26, 2023
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI)Kenta Misaki, Naoto Tamura, Takanori Azuma, et al.
RMD Open|July 10, 2026
Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populationsAya Kawasaki, Ikue Ito-Naito, Mina Sato, et al.
The Journal of Rheumatology|February 17, 2019
Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the WorldMitsumasa Kishimoto, Kazuki Yoshida, Naomi Ichikawa, et al.
Modern Rheumatology|February 19, 2026
Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicenter cohort study (J-CANVAS)Motoki Takeuchi, Yoshiyuki Abe, Ayako Makiyama, et al.
Modern Rheumatology|February 8, 2022
Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren's syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren's Syndrome Endocrinopathy) and ROSE II trialsHiroto Tsuboi, Hirofumi Toko, Fumika Honda, et al.
Lupus|May 6, 2026
Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritisYoshiyuki Abe, Ayako Makiyama, Kentaro Minowa, et al.
Modern Rheumatology|November 10, 2017
Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC)Kenji Oku, Tatsuya Atsumi, Yuji Akiyama, et al.
Pageof 20